- Price Winner — Losing Weight RX: $146/mo flat-rate vs. Mochi Health's $224–$349/mo total cost (consultation fee + tiered medication pricing). LW RX Wins
- No Hidden Fees: Losing Weight RX charges zero membership or consultation fees — Mochi Health layers a $49–$99/mo fee on top of medication costs. LW RX Wins
- No Dose Escalation Surcharges: Losing Weight RX keeps pricing flat at all dose levels. Mochi Health increases medication cost as your dose goes up — pushing your monthly total higher over time.
- 12-Month Savings: Losing Weight RX costs $1,752/year vs. Mochi Health's $2,688–$4,188/year — that's $936–$2,436 in annual savings. LW RX Wins
- Tirzepatide Advantage: Losing Weight RX offers compounded tirzepatide at $258/mo vs. Mochi Health's $299–$399/mo + consultation fee. LW RX Wins
The Quick Verdict
If you're comparing Mochi Health to Losing Weight RX for GLP-1 weight loss treatment, the pricing difference is significant and consistent. Losing Weight RX offers compounded semaglutide at a flat rate of $146 per month — all-inclusive, with no membership fees, no consultation charges, no dose escalation surcharges, and free expedited shipping. Mochi Health, on the other hand, charges $175–$250/mo for medication (depending on your dosage tier) plus a separate $49–$99/mo consultation/membership fee, bringing the real monthly total to $224–$349.
The gap becomes even more pronounced over time. As your dose escalates through the standard titration schedule — which is clinically expected with semaglutide — Mochi Health's medication cost increases accordingly. Losing Weight RX's price stays exactly the same: $146/month, whether you're on a starting dose or a full maintenance dose. Over a 12-month treatment period, the savings add up to $936 to $2,436.
For patients who want compounded GLP-1 medications at a transparent, predictable price, Losing Weight RX is the clear value leader. Let's break down exactly how these two platforms compare across every metric that matters.
What Is Mochi Health?
Mochi Health is a telehealth startup that launched with a laser focus on weight loss medications, particularly GLP-1 receptor agonists like semaglutide and tirzepatide. Unlike diversified telehealth conglomerates that offer everything from skincare to mental health, Mochi Health built its entire platform around one vertical: helping patients access weight loss drugs through online consultations.
The company gained traction quickly, fueled in large part by aggressive social media marketing on platforms like TikTok and Instagram. Mochi Health's influencer-driven campaigns resonated with younger demographics searching for affordable alternatives to brand-name Wegovy and Ozempic, which can cost upwards of $1,300/month without insurance coverage.
Mochi Health offers both compounded and brand-name GLP-1 medications, though the majority of patients gravitate toward their compounded options due to the lower price point. The platform uses asynchronous provider consultations — meaning you communicate with a medical provider via messaging rather than live video calls — and ships medications directly to patients.
While Mochi Health has attracted a loyal following, the platform has also drawn mixed reviews. Some users report positive experiences with responsive customer service and effective medication, while others have flagged concerns about billing transparency, unexpected charges, and difficulty understanding the total cost of treatment when consultation fees are factored in alongside dose-dependent medication pricing.
Company Overview: Losing Weight RX
Losing Weight RX is a telehealth platform that specializes exclusively in compounded GLP-1 medications for medical weight loss. The platform was designed around a single principle: make evidence-based weight loss medications accessible without the pricing complexity, hidden fees, and subscription traps that characterize many telehealth competitors.
The platform operates on a straightforward $146/mo flat-rate model for compounded semaglutide and $258/mo for compounded tirzepatide. Each price covers everything — the medication itself, the medical consultation with a licensed U.S. provider, ongoing clinical support, and free expedited shipping. There are no membership fees, no enrollment fees, no dose escalation charges, and no long-term contracts.
Patients begin by completing a 5-minute online health assessment. A board-certified physician reviews the submission within 24 hours, determines clinical eligibility, and — if appropriate — issues a prescription. The compounded medication is then prepared at a U.S.-licensed compounding pharmacy and cold-shipped directly to the patient's door. The entire process, from assessment to delivery, typically takes 3–5 business days.
Losing Weight RX serves patients in all 50 U.S. states, accepts FSA/HSA payments, and operates on a flexible month-to-month basis. There are no contracts, no auto-renewal traps, and cancellation is handled directly through the patient portal.
How Does Mochi Health's Pricing Actually Work?
Pricing transparency is where the comparison between Losing Weight RX and Mochi Health becomes most stark. Mochi Health's pricing structure involves two separate recurring charges that, when combined, significantly exceed what patients expect based on the headline medication price.
Mochi Health: The Two-Fee Structure
Mochi Health splits its pricing into two components:
- Medication Cost: $175–$250/month for compounded semaglutide (varies by dosage tier) or $299–$399/month for compounded tirzepatide
- Consultation/Membership Fee: $49–$99/month (charged separately, on top of medication)
This brings the real total monthly cost for semaglutide to $224–$349 and the real total for tirzepatide to $348–$498. Over a 12-month treatment period, semaglutide patients can expect to pay $2,688 to $4,188.
GLP-1 medications like semaglutide follow a standard titration protocol: patients start at a low dose and gradually increase over several months to reach a therapeutic maintenance level. On Mochi Health, your medication cost increases as your dose goes up. You might start at the lower end ($175/mo) but reach $250/mo or more at higher maintenance doses. This means your total monthly cost grows steadily — from $224/mo to $349/mo — even though you haven't changed anything about your treatment plan. With Losing Weight RX, your price is locked at $146/mo regardless of your dose level.
Losing Weight RX: One Price, Everything Included
Losing Weight RX charges a single, all-inclusive price:
- Compounded Semaglutide: $146/month (flat rate, all doses)
- Compounded Tirzepatide: $258/month (flat rate, all doses)
- Includes: Medication + medical consultation + clinical support + free expedited shipping
- Membership fee: $0
- Consultation fee: $0
- Dose escalation surcharge: $0
Over 12 months, semaglutide costs $1,752 and tirzepatide costs $3,096.
12-Month Cost Projection: Semaglutide
12-Month Cost Projection: Tirzepatide
The annual savings with Losing Weight RX range from $936 to $2,436 for semaglutide and $1,080 to $2,880 for tirzepatide — enough to fund months of additional treatment.
Save Up to $2,400+ Per Year on GLP-1 Medications
Why pay $224–$349/mo when you can access the same compounded semaglutide through Losing Weight RX for just $146/mo? No consultation fees, no dose surcharges, no contracts.
Start Your AssessmentHow Do the Medications Compare?
Both Losing Weight RX and Mochi Health offer compounded GLP-1 medications — specifically compounded semaglutide and compounded tirzepatide. Understanding the similarities and differences in their medication offerings is essential for making an informed decision. For a deeper exploration of how these two active molecules compare, see our detailed guide: Tirzepatide vs. Semaglutide.
Compounded Semaglutide
Both platforms source compounded semaglutide from U.S.-licensed compounding pharmacies. The active molecule — semaglutide — is identical to the ingredient in brand-name Wegovy and Ozempic. It works by mimicking the GLP-1 hormone, which regulates appetite, slows gastric emptying, and promotes insulin secretion. Clinical trials have demonstrated average weight loss of 12–15% of body weight over 68 weeks with semaglutide treatment.
The difference between Losing Weight RX and Mochi Health isn't in the medication itself — it's in how much you pay for it. Losing Weight RX charges $146/mo regardless of your dose. Mochi Health charges $175–$250/mo depending on your titration level, plus a separate $49–$99/mo consultation fee.
Compounded Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist — the same active ingredient in brand-name Mounjaro and Zepbound. It targets two incretin pathways simultaneously, which clinical data suggests may produce even greater weight loss than semaglutide alone. The SURMOUNT trials demonstrated average weight loss of up to 22.5% of body weight over 72 weeks.
Losing Weight RX offers compounded tirzepatide at $258/month flat. Mochi Health charges $299–$399/month for the medication alone, plus the $49–$99/month consultation fee — bringing the total to $348–$498/month. That's a potential difference of $90 to $240 per month.
Compounded medications are not FDA-approved products. They are, however, legally prepared under federal and state compounding regulations (Section 503A of the FD&C Act) and dispensed pursuant to valid prescriptions from licensed physicians. The active pharmaceutical ingredients are identical to their brand-name counterparts. For a comprehensive safety analysis, read our guide: Is Compounded Semaglutide Safe?
Side-by-Side Comparison Table
The following table presents a comprehensive feature-by-feature comparison between Losing Weight RX and Mochi Health as of May 2026. For similar comparisons with other popular telehealth providers, see our Cheapest Semaglutide Online guide.
| Feature / Metric | Losing Weight RX | Mochi Health |
|---|---|---|
| Monthly Semaglutide Cost | $146 (Flat rate, all-inclusive) | $224–$349 ($175–$250 med + $49–$99 fee) |
| Monthly Tirzepatide Cost | $258 (Flat rate, all-inclusive) | $348–$498 ($299–$399 med + $49–$99 fee) |
| 12-Month Semaglutide Cost | $1,752 | $2,688–$4,188 |
| Consultation / Membership Fee | None ($0) | $49–$99/mo (required) |
| Dose Escalation Fees | No (flat price, all doses) | Yes — medication cost increases with dose |
| Medication Type | Compounded Semaglutide & Tirzepatide | Compounded & Brand-Name GLP-1s |
| Provider Consultation | Included (within 24 hours) | Async consultation (included in fee) |
| Shipping | Free expedited (2–3 day delivery) | Direct to patient (included) |
| Contracts Required | No (month-to-month) | No long-term contract |
| State Availability | All 50 U.S. States | Most U.S. States |
| FSA/HSA Accepted | Yes | Yes |
| Pricing Transparency | One price, fully inclusive | Split fees; cost varies by dose tier |
What Are Users Saying About Mochi Health?
The Positive Feedback
Mochi Health has built a genuine following, particularly among younger patients who discovered the platform through social media. Common praise points include:
- Easy onboarding: The initial sign-up and health questionnaire process is straightforward and mobile-friendly.
- Async convenience: The asynchronous consultation model appeals to patients who prefer messaging over live video calls.
- Medication effectiveness: Many users report meaningful weight loss results with the compounded GLP-1 medications Mochi Health provides.
- Brand-name option: For patients who prefer FDA-approved brand-name medications, Mochi Health offers that path (at a higher cost).
The Common Complaints
However, a growing number of users on Reddit, Trustpilot, and other review platforms have raised concerns about Mochi Health:
- Billing confusion: Multiple users report being surprised by the total cost when the separate consultation fee is factored in. The advertised medication price ($175–$250) does not reflect the full monthly commitment, and some users describe the pricing as misleading.
- Dose escalation cost increases: Patients who start at a lower dose often don't realize their medication cost will increase as they titrate upward. Some users report their monthly bill growing by $50–$75 over the first few months without clear advance notice.
- Billing issues: Some users have reported unexpected charges, difficulty understanding invoices, and challenges resolving billing disputes with customer support.
- Social media vs. reality gap: Several reviewers note that the polished TikTok and Instagram content creates expectations that don't fully align with the actual service experience, particularly around response times and ongoing support.
Losing Weight RX: What Users Experience
Losing Weight RX takes a fundamentally different approach to the patient experience. The pricing is exactly what it appears to be: $146/month for semaglutide, $258/month for tirzepatide, and that's it. There are no separate fees that appear on your credit card statement, no dose-dependent pricing tiers, and no promotional pricing that expires after the first month.
The onboarding process (5-minute health assessment → 24-hour provider review → prescription → cold-shipped delivery) is designed to be frictionless and fully asynchronous. Cancellation is handled directly through the patient portal — no phone calls, no retention departments, no penalty fees. You can pause, modify, or cancel at any time.
Why Does Pricing Transparency Matter for GLP-1 Treatment?
Weight loss medication isn't a one-month commitment. Clinical guidelines and trial data consistently show that GLP-1 treatment delivers optimal results with sustained, long-term use — typically 12 months or longer. The STEP trials for semaglutide and the SURMOUNT trials for tirzepatide both measured outcomes over 68–72 weeks, and researchers have documented significant weight regain in patients who discontinue treatment prematurely.
This means the platform you choose isn't just a one-time decision — it's a financial commitment you'll carry for a year or more. And that's precisely why pricing transparency matters so much.
When a platform charges $175/month for medication but adds a $99/month consultation fee — and then increases the medication price as your dose goes up — the total cost can drift far from what you initially expected. A patient who starts at $224/month may find themselves paying $349/month by month six, without having changed anything about their treatment plan.
Losing Weight RX eliminates this uncertainty entirely. Your price is $146/month from your first injection through your maintenance phase, regardless of dose level. For patients budgeting a 12-month treatment plan, that predictability is worth more than any promotional discount.
Who Should Choose Mochi Health?
In the interest of providing a balanced comparison, there are scenarios where Mochi Health may be the right choice:
- Brand-name preference: If you specifically want access to FDA-approved, brand-name GLP-1 medications (Wegovy, Ozempic, Mounjaro) and are willing to pay the premium, Mochi Health offers both compounded and brand-name options.
- Social media community: Mochi Health has cultivated an active online community, particularly on TikTok and Instagram. If peer support and social accountability are important motivators for your weight loss journey, the community aspect may add value.
- Short-term trial: If you're testing GLP-1 medications for a brief period at a starting dose, Mochi Health's lower-tier medication pricing ($175/mo + $49 fee = $224/mo) is still more expensive than Losing Weight RX but may feel manageable for a short commitment.
Who Should Choose Losing Weight RX?
Losing Weight RX is the clear choice for patients who prioritize:
- Affordability: At $146/mo for semaglutide and $258/mo for tirzepatide, Losing Weight RX costs significantly less than Mochi Health at every dose level. Over a year, the savings are substantial — up to $2,436 for semaglutide and $2,880 for tirzepatide.
- Pricing predictability: No membership fees, no consultation fees, no dose escalation surcharges, no promotional pricing that expires. One price, every month, for the duration of your treatment.
- Flexibility: Month-to-month treatment with no contracts and easy portal-based cancellation. You're never locked in.
- Speed: 24-hour provider review and free expedited shipping means you can start treatment quickly. No mandatory video appointments or scheduling delays.
- National coverage: Losing Weight RX serves patients in all 50 U.S. states — no geographic restrictions or waitlists.
- The same active molecule: Compounded semaglutide and tirzepatide from Losing Weight RX deliver the identical GLP-1 active ingredients as what Mochi Health provides, prepared by U.S.-licensed pharmacies.
Frequently Asked Questions (FAQs)
The real total monthly cost of Mochi Health for compounded semaglutide ranges from $224 to $349 per month. This includes a $49–$99 monthly consultation/membership fee on top of $175–$250 for the medication. The medication cost increases as you escalate to higher doses, so your total monthly bill tends to rise over time. Over 12 months, expect to pay $2,688–$4,188.
Yes. Mochi Health charges a separate monthly consultation or membership fee of $49–$99, depending on the plan tier. This fee is charged on top of the medication cost. Losing Weight RX, by contrast, includes the medical consultation, ongoing support, and free expedited shipping in its flat $146/month rate — no separate fees of any kind.
Yes. Mochi Health uses a tiered pricing model where the cost of medication increases as your dosage escalates. Starting doses may cost around $175/month, but higher maintenance doses can reach $250/month or more. When combined with the monthly consultation fee, your total cost grows over time. Losing Weight RX charges $146/month for semaglutide regardless of dose level — your price never changes.
Both Losing Weight RX and Mochi Health provide compounded semaglutide — the same active GLP-1 receptor agonist molecule used in brand-name Wegovy and Ozempic. Both source from U.S.-licensed compounding pharmacies. The key difference is in pricing: Losing Weight RX charges $146/month all-inclusive, while Mochi Health charges $175–$250/month for the medication plus a $49–$99/month consultation fee.
You can save between $936 and $2,436 per year on semaglutide by choosing Losing Weight RX ($146/mo, $1,752/year) over Mochi Health ($224–$349/mo, $2,688–$4,188/year). For tirzepatide, annual savings range from $1,080 to $2,880 — Losing Weight RX charges $258/mo ($3,096/year) vs. Mochi Health's $348–$498/mo ($4,176–$5,976/year).
Yes. Losing Weight RX offers compounded tirzepatide at a flat rate of $258/month, which includes medication, consultation, and free expedited shipping. Mochi Health charges approximately $299–$399/month for compounded tirzepatide plus a separate $49–$99/month consultation fee, bringing the total to $348–$498/month. Losing Weight RX saves you $90–$240 per month on tirzepatide.
Final Recommendation: Which Platform Offers Better Value?
When comparing Losing Weight RX and Mochi Health in 2026, the value proposition is clear. Both platforms offer compounded GLP-1 medications sourced from U.S.-licensed pharmacies. Both provide asynchronous provider consultations and ship medications directly to patients. The difference is entirely in what you pay — and how transparent that pricing is.
Mochi Health markets aggressively on social media and has built a recognizable brand, but its two-fee pricing structure and dose-dependent medication costs create a moving target for patients trying to budget their treatment. A patient who expects to pay $175/month may find themselves paying $349/month within a few months as consultation fees and dose escalation charges stack up.
Losing Weight RX offers the same compounded semaglutide at $146/month flat and the same compounded tirzepatide at $258/month flat. No membership fees, no consultation fees, no dose escalation surcharges, and no contracts. The savings are real: up to $2,436 per year for semaglutide and up to $2,880 per year for tirzepatide.
If you're currently on Mochi Health and looking for a more affordable alternative, or if you're just beginning your GLP-1 weight loss journey and want the most honest, predictable pricing available, Losing Weight RX is the clear value leader in 2026.
Get Semaglutide for $146/mo — No Membership Required
Complete your 5-minute online assessment, get evaluated by a U.S.-licensed provider within 24 hours, and receive your treatment shipped directly to your door. No hidden fees. No contracts. No surprises.
Get Started TodayClinical References & Sources
- Wilding, J.P.H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 384(11), 989-1002. NEJM Full Text
- Jastreboff, A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 387(3), 205-216. NEJM Full Text
- U.S. Food and Drug Administration. (2024). Human Drug Compounding Under Section 503A of the FD&C Act. FDA.gov Guidance
- National Institutes of Health. (2025). Clinical trials database for semaglutide efficacy. ClinicalTrials.gov (NCT03548935)
- U.S. Food and Drug Administration. (2026). FDA Drug Shortages Database. FDA Shortages Log